Middle market private equity firm Gryphon Investors (Gryphon) has completed the sale of RoC Skincare (RoC) to Bridgepoint Europe VII, a fund focused on investing in mid-market growth businesses. Financial terms have not been disclosed.
RoC was founded in Paris in 1957 by Dr Jean-Charles Lissarrague and offers skin health solutions with a focus on ageing skin. The company’s products are sold globally, including in the US, Canada, Europe, Australia and China.
Since Gryphon’s initial investment in 2019, RoC has experienced significant organic growth, broadened its distribution footprint in the US and internationally, and expanded its product portfolio.
RoC was advised by Raymond James for M&A, Kirkland & Ellis for legal and PwC for financial and tax due diligence. Gryphon was advised in the transaction by CG Sawaya Partners (operating under Canaccord Genuity), which also originally advised on the sale of Roc Skincare from Johnson & Johnson Consumer.
